洛克希德馬丁(LMT.US)向美國陸軍交付第一款新型火箭發射器M270A2
格隆匯7月13日丨國防承包商洛克希德馬丁(LMT.US)公司週二表示,它已將其最新移動火箭發射器的第一個模型移交給美國陸軍。美國及其盟國最近向烏克蘭提供了價值數十億美元的武器,以幫助其擊退俄羅斯的入侵,莫斯科稱這是一次“特殊行動”。洛克希德馬丁表示,這種名為M270A2的新型多管火箭系統可以由大型軍用運輸機C-17和C-5運輸。M270A2的客户英國上個月表示,它將向烏克蘭提供一些較舊的多管火箭系統,這些系統可以打擊最遠80公里(50英里)以外的目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.